Skip to main content

Table 3 Secondary outcomes stratified by under 5 years of age and over 5 years of age

From: In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia

Outcome

≤5 years of age

>5 years of age

Total

Fever*, n/N (%)

   

   Day 1

9/23 (39.1)

32/95 (33.7)

41/118 (34.8)

   Day 2

1/22 (4.6)

10/94 (10.6)

11/116 (9.5)

   Day 3

0/21 (0)

8/94 (8.5)

8/115 (7.0)

Parasitaemia, n/N (%)

   

   Day 2

5/22 (22.7)

3/94 (3.2)

8/116 (6.9)

   Day 3

1/21 (4.8)

0/94 (0)

1/115 (0.9)

Gametocytaemia, n/N (%)

   

   Day 2

6/22 (27.3)

8/94 (8.5)

14/116 (12.1)

   Day 3

1/21 (4.8)

5/94 (5.3)

6/115 (5.2)

   Day 7

0

4/94 (4.3)

4/115 (3.5)

   Day 14

0

1/94 (1.1)

1/115 (0.9)

Mean Haemoglobin g/dL, mean (SD)

   

   Day 28

12.0 (1.2)

13.7 (1.8)

13.4 (1.8)

   Day 42

12.0 (1.1)

13.8 (1.8)

13.5 (1.8)

Mean Difference in Haemoglobin Day 0 to 42 g/dL, (SD)

1.9 (1.9)

0.7 (2.1)

0.9 (2.1)

  1. *Subjective fever or axillary temperature ≥37.5°C